Novo Nordisk
NVO
#23
Rank
โ‚น35.754 T
Marketcap
โ‚น7,927
Share price
1.60%
Change (1 day)
-21.33%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.592 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น41.89 Billion. , an increase over its 2023 earnings that were of โ‚น1.349 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น1.656 T22.75%
2023 โ‚น1.349 T57.64%
2022 โ‚น855.93 B5.35%
2021 โ‚น812.46 B12.47%
2020 โ‚น722.38 B13.07%
2019 โ‚น638.88 B-3.35%
2018 โ‚น661.03 B1.79%
2017 โ‚น649.37 B4.52%
2016 โ‚น621.28 B9.42%
2015 โ‚น567.81 B8.24%
2014 โ‚น524.59 B3.45%
2013 โ‚น507.11 B19.02%
2012 โ‚น426.08 B15.21%
2011 โ‚น369.84 B17.71%
2010 โ‚น314.19 B24.78%
2009 โ‚น251.79 B10.62%
2008 โ‚น227.60 B55.97%
2007 โ‚น145.93 B7.07%
2006 โ‚น136.30 B18.18%
2005 โ‚น115.33 B11.33%
2004 โ‚น103.59 B
2002 โ‚น64.42 B-14.39%
2001 โ‚น75.24 B-52.82%
2000 โ‚น159.48 B250%
1999 โ‚น45.56 B31.21%
1998 โ‚น34.72 B34.31%
1997 โ‚น25.85 B11.46%
1996 โ‚น23.19 B9.03%
1995 โ‚น21.27 B-3.15%
1994 โ‚น21.96 B-0.67%
1993 โ‚น22.11 B45.38%
1992 โ‚น15.21 B-13.81%
1991 โ‚น17.64 B37.12%
1990 โ‚น12.87 B-0.79%
1989 โ‚น12.97 B26.2%
1988 โ‚น10.27 B24.97%
1987 โ‚น8.22 B-0.9%
1986 โ‚น8.30 B-7.78%
1985 โ‚น9.00 B24.87%
1984 โ‚น7.20 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น607.14 B-63.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.108 T-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น732.72 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น694.50 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France